Archivio news

newsroom
Titolo Data
KLISBio ottiene €2,5M da EIC Accelerator Program per supportare la crescita aziendale in Europa 28.02.24
KLISBio Secures €2.5 Million Grant by the EIC Accelerator Program to Propel Growth in Europe 28.02.24
KLISBio to participate at 78TH ANNUAL MEETING OF THE ASSH 29.09.23
KLISBio to participate at 2023 FESSH-EFSHT Combined Congress With an e-poster presentation on SILKBridge 09.05.23
KLISBio to participate at 2023 AAHS, ASPN & ASRM Annual Meeting 17.01.23
KLISBio to participate at 2022 IFSSH, IFSHT & FESSH Combined Congress With an abstract presentation on SILKBridge 01.06.22
KLISBio, Company history 13.05.22
KLISBio to present SILKBridge for peripheral nerve repair and its innovative silk-based tissue-engineered technology platform at 2022 Bio€quity Europe 10.05.22
KLISBio to share its leading-edge silk-based technology platform at 2022 AAOS Annual Meeting 23.03.22
KLISBio to disclose state-of-the-art tissue-engineered technology platform at 2022 CG Musculoskeletal Conference 22.03.22
KLISBio to unveil cutting-edge silk-based technology platform at 2022 Digital RESI Conference 21.03.22
KLISBio to share innovative tissue-engineered technology at LSI 2022 Emerging MedTech Summit 14.03.22
KLISBio appoints Rodrigo Bianchi as new Chairman of the Board 12.01.22
KLISBio to feature engineered silk innovation at Biotech Showcase 11.01.22
KLISBio to feature engineered silk innovation at AAHS 2022 11.01.22
Silk Biomaterials ushers in the next evolution of life sciences innovation with rebranding and new name 11.01.22
KLISBio to share innovative tissue-engineered technology at BIO Partnering with JP Morgan 11.01.22